According to Immunocore's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.22. At the end of 2024 the company had a P/S ratio of 9.59.
Year | P/S ratio | Change |
---|---|---|
2024 | 9.59 | -10.17% |
2023 | 10.7 | -14.71% |
2022 | 12.5 | -58.76% |
2021 | 30.3 |